Articles published by Travere Therapeutics, Inc.
Travere Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Reports Third Quarter 2023 Financial Results
November 07, 2023
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Report Third Quarter 2023 Financial Results
October 24, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023
October 13, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 11, 2023
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)
September 26, 2023
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 11, 2023
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Via GlobeNewswire
Tickers
TVTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.